Skip to main content
ELVN logo

ELVN · Enliven Therapeutics, Inc.

Track ELVN — free
$57.86 -2.64 (-4.36%) At close · Aug 28
Market Cap
$4.24B
Shares
73.27M

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

ELVN Short Interest Forecast

Equibles' model estimates 8,363,200 shares sold short for the August 31, 2026 settlement, +1.3% versus the latest reported position. This model prediction uses FINRA data through August 21, 2026; FINRA's official release is expected September 10, 2026.

Model estimate

Expected Aug 31 short interest

as of Aug 21
8,363,200 +1.3% vs reported
The latest estimate appears in the chart below. Official release expected Sep 10. Methodology
Short Squeeze Score
76/100
Short interest 11.3% of shares — P92 Days to cover 6.3 — P78 Price vs VWAP +17.4% — P90 Short-volume trend +5.7% — P71 Short interest change +1.3% — P59 Worst FTD 0.00% of shares — P30

Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-08-14). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.

Short Interest History

Settlement Date Current Position Previous Position Change Days to Cover
2026-09-15 Scheduled
FINRA publishes Sep 24
2026-08-31 Scheduled
FINRA publishes Sep 10
2026-08-14 8,258,991 8,151,554 +107,437 6.33
2026-07-31 8,151,554 8,651,596 -500,042 11.44
2026-07-15 8,651,596 8,527,025 +124,571 9.41
2026-06-30 8,527,025 5,426,405 +3,100,620 3.09
2026-06-15 5,426,405 5,213,383 +213,022 2.61
2026-05-29 5,213,383 5,122,350 +91,033 8.73
2026-05-15 5,122,350 5,273,791 -151,441 8.05
2026-04-30 5,273,791 5,374,014 -100,223 6.86
2026-04-15 5,374,014 6,053,456 -679,442 4.28
2026-03-31 6,053,456 8,215,500 -2,162,044 2.86
2026-03-13 8,215,500 7,979,674 +235,826 10.54
2026-02-27 7,979,674 8,078,549 -98,875 12.26
2026-02-13 8,078,549 7,870,182 +208,367 11.21
2026-01-30 7,870,182 9,166,736 -1,296,554 7.89
2026-01-15 9,166,736 8,312,949 +853,787 4.19
2025-12-31 8,312,949 8,111,262 +201,687 11.85
2025-12-15 8,111,262 7,996,827 +114,435 9.81
2025-11-28 7,996,827 7,794,126 +202,701 14.74
2025-11-14 7,794,126 7,782,638 +11,488 10.37
2025-10-31 7,782,638 6,422,840 +1,359,798 18.19
2025-10-15 6,422,840 5,699,585 +723,255 15.53
2025-09-30 5,699,585 4,856,687 +842,898 8.22
2025-09-15 4,856,687 4,891,510 -34,823 10.19

Full FINRA short interest reporting calendar

Showing 1–23 of 23 settlements
Key facts CIK 1672619 CUSIP 29337E102 13F (30d) 196 filings 193 filers Visit website Investor relations